Every story in this section, newest first — page 54 of 373.
Permian Basin Royalty Trust (NYSE:PBT) declared a September 2026 cash distribution of $0.019593 per unit, totaling $913,228.22, payable on October 15, 2026, to unitholders of record as of September 30, 2026.
Philip Morris International (NYSE:PM) increased its regular quarterly dividend by 8.8% to $1.60 per share, representing an annualized dividend rate of $6.40 per share.
Chanson International Holding (NASDAQ:CHSN) reported net income of $0.8 million for the six months ended June 30, 2026, compared with a net loss of $1 million in the same period a year earlier.
Abeona Therapeutics (NASDAQ:ABEO) announced that Ultragenyx Pharmaceutical received U.S. Food and Drug Administration approval for FAYUVI (rebisufligene etisparvovec-hopf), a gene therapy for Sanfilippo syndrome type A.
Santacruz Silver Mining (NASDAQ:SCZM) acquired a 500-tonne-per-day milling facility in Bolivia to process ore from its wholly owned subsidiary San Lucas and support expansion of its third-party ore-sourcing business.
MISTRAS Group (NYSE:MG) agreed to be acquired by affiliates of H.I.G. Capital for $20.35 per share in cash, representing an enterprise value of approximately $866 million including outstanding debt.
BlossomHill Therapeutics (NASDAQ:BLSM) reported second quarter 2026 financial results and pipeline progress, highlighting its strengthened cash position following an upsized initial public offering.
The Cato Corporation (NYSE:CATO) plans to close approximately 70 additional underperforming stores during the third and fourth quarters of fiscal 2026, bringing total planned store closures for the year to about 120 locations.
Merck (NYSE:MRK) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending KEYTRUDA (pembrolizumab) combined with Padcev (enfortumab vedotin-ejfv) for adults with resectable muscle-invasive bladder cancer.
Xenon Pharmaceuticals (NASDAQ:XENE) shares declined after the company temporarily paused new patient enrollment in clinical studies evaluating its drug candidate for major depression and bipolar depression.
Novo Nordisk (NYSE:NVO) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending once-weekly Sogroya (somapacitan) for children in Europe with idiopathic short stature and persistent growth disturbance.
U.S.-listed gold mining shares gained before the market opened as rising bullion prices lifted the sector, with spot gold reaching $4,377.32 per ounce.
The Ensign Group (NASDAQ:ENSG) declared a quarterly cash dividend of $0.0650 per share of common stock, payable on or before October 31, 2026.
Natera (NASDAQ:NTRA) presented new data from its Signatera molecular residual disease (MRD) test at the IASLC 2026 World Conference on Lung Cancer, including results from a 1,129-patient analysis in early-stage non-small cell lung cancer.
Nasdaq 100 futures led U.S. stock futures higher on Friday as declining oil prices reduced some inflation concerns and put the technology-focused index on track for weekly gains.
Brent crude and West Texas Intermediate oil prices declined for a third consecutive session as easing concerns over Saudi Arabian supply disruptions outweighed concerns about a wider Middle East conflict.
Nestlé said it is reviewing options after the Russian government placed its local business under temporary control through a presidential decree.
Taboola (NASDAQ:TBLA) announced an offer to acquire Dianomi, a digital advertising provider specializing in business, finance and lifestyle advertising.
Pearson (NYSE:PSO) acquired assessment technology provider ITS to strengthen its global assessment and verification capabilities.
W. P. Carey (NYSE:WPC) announced that its Board of Directors increased the quarterly cash dividend to $0.950 per share, representing an annualized dividend rate of $3.80 per share.
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) received authorization from Health Canada for their Omicron XFG-adapted COVID-19 vaccine.
Intuit (NASDAQ:INTU) provided fiscal 2027 guidance, expecting full-year revenue of $23.28 billion to $23.51 billion and first-quarter revenue of $4.29 billion to $4.31 billion.
Surgery Partners (NASDAQ:SGRY) updated its 2026 financial outlook following the completed sale of its Idaho Falls facilities to Intermountain Health.
Olenox Industries (NASDAQ:OLOX) reported that its CS Digital Ventures operations mined approximately 15.63 Bitcoin in August 2026 as the company continued operating its digital asset mining infrastructure.
